Outcome of the Board Meeting - May 4, 2026
TATACHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Tata Chemicals reported a consolidated net loss of ₹1,715 crore for FY2026, a sharp reversal from a profit of ₹387 crore in FY2025, driven primarily by a ₹1,837 crore goodwill impairment charge on its US operations due to adverse market conditions and geopolitical factors. Revenue from operations declined marginally to ₹14,584 crore from ₹14,887 crore. The Basic Chemistry segment bore a loss of ₹1,311 crore due to the impairment, while EBITDA margin compressed to 4.14% from 5.58% in the prior year. Exceptional items net totaled ₹1,956 crore, including ₹65 crore additional costs from the UK Lostock plant closure and ₹54 crore from new Indian labour codes. The Board recommended a dividend of ₹11 per share (110%), unchanged from the prior year. Statutory auditors BSR & Co. LLP issued an unmodified opinion. The company has a net worth of ₹22,175 crore and total debt of ₹8,001 crore (Debt-Equity 0.36x).
The large goodwill impairment and operating loss signal stress in the US business and legacy UK operations, though the underlying operating performance excluding one-time items remains under pressure. The unchanged dividend provides some comfort to shareholders despite the loss-making year.